Shalini M M - OmicsDI

Show results for

Unknown (16)
Genomics (12)
Transcriptomics (10)
Metabolomics (2)
Proteomics (2)
Models (1)

Organisms

Homo sapiens (20)
Klebsormidium nitens (1)
Oryza sativa (1)
Ovis aries (1)
Mus musculus (1)

Repository

biostudies-arrayexpress (14)
EGA (7)
MetaboLights (2)
BioModels (1)
PanoramaPublic (1)
pride (1)
ENA (1)

Tissue

Rheumatoid arthritis disease specific synovial fluid (1)

Disease

Psoriatic arthritis (1)
Rheumatoid arthritis (1)

Technology Type

Mass spectrometry (2)
Illumina HiSeq 2000 (1)
Mass Spectrometry (1)
Shotgun proteomics (1)

Instrument Platform

Illumina NovaSeq 6000 (2)
Liquid Chromatography MS - positive - reverse phase (2)
Illumina Genome Analyzer IIx (1)
Illumina NovaSeq X (1)
Illumina HiSeq 2000 (1)

Publication Date

2025 (4)
2022 (3)
2011 (3)
2019 (2)
2016 (2)
2014 (2)
2015 (1)
2007 (1)
2024 (1)

CHEBI ID

CHEBI:10106 (2)
CHEBI:10135 (2)
CHEBI:102216 (2)
CHEBI:111173 (2)
CHEBI:116314 (2)
CHEBI:1217 (2)
CHEBI:134485 (2)
CHEBI:134750 (2)
CHEBI:134758 (2)
CHEBI:134827 (2)
CHEBI:134834 (2)
CHEBI:134894 (2)
CHEBI:134934 (2)
CHEBI:135291 (2)
CHEBI:135566 (2)
CHEBI:135932 (2)
CHEBI:137055 (2)
CHEBI:137125 (2)
CHEBI:137268 (2)
CHEBI:1391 (2)
CHEBI:142245 (2)
CHEBI:142683 (2)
CHEBI:143054 (2)
CHEBI:143870 (2)
CHEBI:1458 (2)
CHEBI:156235 (2)
CHEBI:15746 (2)
CHEBI:15756 (2)
CHEBI:1582 (2)
176843 (1)

Metabolite Name

(-)-Octanoylcarnitine (2)
(-)-Rhododendrin (2)
(-)-THREO-SPHINGOSINE (2)
(2E)-2-Tridecene-4,6,8-triyn-1-ol (2)
(2E,4E,12Z)-N-Isobutyl-2,4,12-octadecatrienamide (2)
(2R,3R,4S,5S,6R)-2-[(3Z)-hex-3-en-1-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol (2)
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(2-phenylethoxy)oxane-3,4,5-triol (2)
(2R,3S,4S,5S,6R)-2-({7-hydroxy-4-[(3Z)-5-hydroxy-3-methylpent-3-en-1-yl]-4a,8,8-trimethyl-3-methylidene-decahydronaphthalen-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol (2)
(2S)-2-Amino-8-hydroxyoctanoic acid (2)
(3S)-3-Amino-2-azepanone (2)
(4E)-1,7-Bis(4-hydroxyphenyl)-4-hepten-3-one (2)
(9E,12E)-9,12-Octadecadienoic acid (2)
(9Z)-9-Octadecenamide (2)
(E)-Dacarbazine (2)
(E)-p-coumaric acid (2)
(Z)-3-butylidene-7-hydroxyphthalide (2)
(Z)-Hex-3-enyl benzoate (2)
1,2-Cyclohexadione (2)
1,3,7-Octanetriol (2)
1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol (2)
1-(4-methylphenyl)-3,5-diphenylpent-2-ene-1,5-dione (2)
1-Allyl-2,3,4,5-tetramethoxybenzene (2)
1-Heptanethiol (2)
1-Hexadecanoyl-sn-glycero-3-phosphocholine (2)
1-Hexyl-2-methylbenzene (2)
1-Linoleoyl-sn-glycero-3-phosphocholine (2)
1-Monopalmitoylglycerol (2)
1-Oleoyl-rac-glycerol (2)
1-Tetradecylamine (2)
1-[2,6-Dimethyl-4-(2-methyl-2-propanyl)-3,5-dinitrophenyl]ethanone (2)

IsPrivate

False (1)

First Public Date

2026 (1)

Modelling Approach

Ordinary differential equation model (1)

Study type

RNA-seq of coding RNA (6)
Transcription profiling by array (4)
ChIP-seq (2)
DNA-seq (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2025 (4)
2020 (4)
2016 (3)
2014 (3)
2011 (3)
2024 (3)
2022 (2)
2018 (2)
2019 (1)
2015 (1)
2007 (1)
2021 (1)
2009 (1)
2026 (1)

Lab affiliation

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada Department of Clinical Biochemistry, University Health Network, Toronto, ON, Canada Centre for Prognosis Studies in Rheumatic Diseases, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada, 11Institute of Medical Science, University of Toronto, Toronto, ON, Canada (1)

Tags

xref:PubMed:39577934 (1)

Previous page
1 / 5
You're on page 1
page 2
page 3
page 4
page 5
Next page

Sort by:

Relevance

Page size

CTCF promotes RNA pol II pausing and links DNA methylation to alternative splicing [ChIP-Seq]

The goal of this study was to investigate the role of intragenic CTCF in alternative pre-mRNA splicing through a combined CTCF-ChIP-seq and RNA-seq approach. CTCF depletion led to decreased inclusion of weak upstream exons. CTCF ChIP-seq was performed in BJAB and BL41 B cell lines and normalized rel...

ORGANISM(S): Homo sapiens

2011-10-06 | E-GEOD-31485 | biostudies-arrayexpress

Pharmacogenetic studies update in type 2 diabetes mellitus.

Not available

S-EPMC4980637 | biostudies-literature

Nickel sulfide-incorporated sulfur-doped graphitic carbon nitride nanohybrid interface for non-enzymatic electrochemical sensing of glucose.

Not available

S-EPMC9418721 | biostudies-literature

CTCF promotes RNA pol II pausing and links DNA methylation to alternative splicing

This SuperSeries is composed of the following subset Series: GSE31485: CTCF promotes RNA pol II pausing and links DNA methylation to alternative splicing [ChIP-Seq] GSE31486: CTCF promotes RNA pol II pausing and links DNA methylation to alternative splicing [RNA-Seq] Refer to individual Series

ORGANISM(S): Homo sapiens

2011-10-05 | E-GEOD-31278 | biostudies-arrayexpress

Transcription profiling of MCF-7 cell lines stably overexpressing constitutively active Raf-1, constitutively active MEK, constitutively active c-erbB-2, or ligand-activatable EGFR as models of overexpressed growth factor signaling

Profiling of MCF-7 cell lines stably overexpressing constitutively active Raf-1, constitutively active MEK, constitutively active c-erbB-2, or ligand-activatable EGFR as models of overexpressed growth factor signaling, as well as control vector transfected cells (coMCF-7) and control vector transfec...

ORGANISM(S): Homo sapiens

2007-10-02 | E-GEOD-3542 | biostudies-arrayexpress

CTCF promotes RNA pol II pausing and links DNA methylation to alternative splicing [RNA-Seq]

ORGANISM(S): Homo sapiens

2011-10-06 | E-GEOD-31486 | biostudies-arrayexpress

5-Dichloro-acetyl-4-methyl-2,3,4,5-tetra-hydro-1H-1,5-benzodiazepin-2-one hemihydrate.

Not available

S-EPMC2970202 | biostudies-literature

Dental implant placement accuracy with robotic surgery compared to free-hand, static and dynamic computer assisted techniques: Systematic review and meta-analysis

Not available

S-EPMC11696845 | biostudies-literature

Synthesis and in vitro anti-proliferative evaluation of naphthalimide-chalcone/pyrazoline conjugates as potential SERMs with computational validation.